- Home
- SIGA vs RXST Comparison
SIGA vs RXST Comparison
Compare SIGA & RXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SIGA | RXST |
|---|---|---|
| Founded | 1995 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.8M | 208.8M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SIGA | RXST |
|---|---|---|
| Price | $3.27 | $4.87 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $7.57 |
| AVG Volume (30 Days) | 474.4K | ★ 603.1K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | ★ 18.75% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $9.36 |
| Revenue Next Year | $170.70 | $1.42 |
| P/E Ratio | $24.65 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.83 | $4.40 |
| 52 Week High | $8.46 | $13.22 |
Technical Indicators
Market Signals| Indicator | SIGA | RXST |
|---|---|---|
| Relative Strength Index (RSI) | 55.63 | 43.67 |
| Support Level | $3.02 | $4.55 |
| Resistance Level | $3.32 | $4.98 |
| Average True Range (ATR) | 0.10 | 0.24 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 75.59 | 53.19 |
Price Performance
Historical ComparisonAbout SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
About RXST RxSight Inc.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.